We are live on ! Find out more
GDRX icon

GoodRx Holdings

170 hedge funds and large institutions have $633M invested in GoodRx Holdings in 2024 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

253% more call options, than puts

Call options by funds: $4.22M | Put options by funds: $1.2M

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

31% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 35

13% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 47

1% more funds holding

Funds holding: 168170 (+2)

13.83% less ownership

Funds ownership: 144.32%130.49% (-14%)

36% less capital invested

Capital invested by funds: $988M → $633M (-$355M)

Holders
170
Holders Change
+2
Holders Change %
+1.19%
% of All Funds
2.24%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
53
Increased
46
Reduced
35
Closed
47
Calls
$4.22M
Puts
$1.2M
Net Calls
+$3.02M
Net Calls Change
+$930K
Name Holding Trade Value Shares
Change
Change in
Stake
State of Wisconsin Investment Board
76
State of Wisconsin Investment Board
Wisconsin
$248K +$65.5K +11,909 +29%
HighTower Advisors
77
HighTower Advisors
Illinois
$233K -$1.05K -192 -0.4%
LPL Financial
78
LPL Financial
California
$215K +$123K +22,436 +94%
Parallax Volatility Advisers
79
Parallax Volatility Advisers
California
$204K +$233K +42,443 +2,960%
Mirae Asset Global ETFs Holdings
80
Mirae Asset Global ETFs Holdings
Hong Kong
$201K -$50.8K -9,250 -18%
CC
81
Centiva Capital
New York
$197K -$132K -23,975 -36%
Marshall Wace
82
Marshall Wace
United Kingdom
$195K
KCPG
83
Kavar Capital Partners Group
Kansas
$191K
BNP Paribas Financial Markets
84
BNP Paribas Financial Markets
France
$183K +$216K +39,285 New
BWA
85
Bordeaux Wealth Advisors
California
$173K
CIC
86
Cornercap Investment Counsel
Georgia
$170K
CC
87
Corton Capital
Ontario, Canada
$163K +$192K +34,960 New
Invesco
88
Invesco
Georgia
$160K -$3.97K -722 -2%
HWM
89
Hohimer Wealth Management
Washington
$151K +$179K +32,560 New
Janus Henderson Group
90
Janus Henderson Group
United Kingdom
$151K
BHCM
91
Brevan Howard Capital Management
Jersey
$148K +$175K +31,776 New
OR
92
Olympiad Research
Connecticut
$147K +$173K +31,530 New
GL
93
Gerber LLC
Ohio
$145K
PCM
94
Prelude Capital Management
New York
$139K +$164K +29,924 New
JG
95
Jain Global
New York
$137K +$162K +29,477 New
Deutsche Bank
96
Deutsche Bank
Germany
$137K +$161K +29,380 New
CIAS
97
Capital Investment Advisory Services
North Carolina
$137K -$13.2K -2,400 -8%
Wells Fargo
98
Wells Fargo
California
$128K -$448K -81,454 -75%
SMAM
99
Sugar Maple Asset Management
Wisconsin
$122K +$144K +26,250 New
PP
100
PDT Partners
New York
$119K +$140K +25,510 New

GDRX Hedge Fund Activity: Q4 2024 in Review

170 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q4 2024, worth a combined $633M — down 36% from $988M a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new GDRX positions and 47 closed out — a net gain of 6 holders — while 46 added to existing stakes and 35 trimmed.

The largest buyer was ClearBridge Investments, opening a new position worth an estimated $6.93M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $26.5M sold.

  • 170 institutional investors held GoodRx Holdings (GDRX) as of Q4 2024, up from 168 in Q3 2024.
  • Funds reported $633M of GoodRx Holdings stock for Q4 2024, down 36% quarter-over-quarter.
  • 53 funds opened new GoodRx Holdings positions in Q4 2024 and 47 closed out, a net change of +6 holders.
  • The largest GoodRx Holdings buyer in Q4 2024 was ClearBridge Investments, an estimated $6.93M added.
  • The largest GoodRx Holdings seller in Q4 2024 was T. Rowe Price Investment Management, an estimated $26.5M sold.

Based on aggregated 13F filings for Q4 2024.